These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Effect of infusion therapy on central hemodynamics and the outcome of treatment in patients with subarachnoidal hemorrhages]. Shatalov VI; Shchegolev AV Anesteziol Reanimatol; 2005; (4):55-8. PubMed ID: 16206589 [TBL] [Abstract][Full Text] [Related]
25. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Smith WS; Dowd CF; Johnston SC; Ko NU; DeArmond SJ; Dillon WP; Setty D; Lawton MT; Young WL; Higashida RT; Halbach VV Stroke; 2004 Nov; 35(11):2518-22. PubMed ID: 15472097 [TBL] [Abstract][Full Text] [Related]
26. [Differences in outcome in patients with poor grade subarachnoid hemorrhage (WFNS grade IV and V): according to the perioperative management against vasospasm]. Goto Y; Yamagata S No Shinkei Geka; 2004 Jun; 32(6):579-84. PubMed ID: 15352627 [TBL] [Abstract][Full Text] [Related]
27. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy? Zemke D; Farooq MU; Mohammed Yahia A; Majid A Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485 [TBL] [Abstract][Full Text] [Related]
28. Vasospasm following aneurysmal subarachnoid hemorrhage: The search for the elusive wonder-drug. Menon G Neurol India; 2018; 66(2):423-425. PubMed ID: 29547165 [No Abstract] [Full Text] [Related]
29. Critical care guidelines on the endovascular management of cerebral vasospasm. Kimball MM; Velat GJ; Hoh BL; Neurocrit Care; 2011 Sep; 15(2):336-41. PubMed ID: 21761272 [TBL] [Abstract][Full Text] [Related]
30. Stellate ganglion block as alternative to intrathecal papaverine in relieving vasospasm due to subarachnoid hemorrhage. Prabhakar H; Jain V; Rath GP; Bithal PK; Dash HH Anesth Analg; 2007 May; 104(5):1311-2. PubMed ID: 17456713 [No Abstract] [Full Text] [Related]
31. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management. Liu-Deryke X; Rhoney DH Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324 [TBL] [Abstract][Full Text] [Related]
32. Bedside monitoring of cerebral blood flow in patients with subarachnoid hemorrhage. Hegner T; Krayenbühl N; Hefti M; Yonekawa Y; Keller E Acta Neurochir Suppl; 2001; 77():131-4. PubMed ID: 11563271 [No Abstract] [Full Text] [Related]
33. Re: Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity (Prevedello DM et al. Surg Neurol 2006;65:S1:14-S1:21). Wong GK; Poon WW Surg Neurol; 2006 Jul; 66(1):110; author reply 110-1. PubMed ID: 16793465 [No Abstract] [Full Text] [Related]
34. Sodium nitrite as a therapeutic agent for central nervous system diseases. Pluta RM; Oldfield EH Surg Neurol; 2006 Jul; 66(1):5-7; discussion 8-10. PubMed ID: 16793425 [No Abstract] [Full Text] [Related]
35. Effects of extract of Ginkgo biloba on spasms of the basilar artery and cerebral microcirculatory perfusion in rats with subarachnoid hemorrhage. Sun BL; Zhang J; Wang XC; Xia ZL; Yang MF; Zhang SM; Ye WJ; Yuan H Clin Hemorheol Microcirc; 2003; 29(3-4):231-8. PubMed ID: 14724346 [TBL] [Abstract][Full Text] [Related]
36. Endovascular treatment of cerebral vasospasm following S.A.H. Barreau X; Pastore M; Piotin M; Spelle C; Moret J Acta Neurochir Suppl; 2001; 77():177-80. PubMed ID: 11563281 [No Abstract] [Full Text] [Related]
37. Advances in vasospasm treatment and prevention. Komotar RJ; Zacharia BE; Valhora R; Mocco J; Connolly ES J Neurol Sci; 2007 Oct; 261(1-2):134-42. PubMed ID: 17570400 [TBL] [Abstract][Full Text] [Related]